Literature DB >> 2820544

Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies.

B Hofmann1, B O Lindhardt, J Gerstoft, C S Petersen, P Platz, L P Ryder, N Odum, E Dickmeiss, P B Nielsen, S Ullman.   

Abstract

To identify factors that may predict the development of the acquired immune deficiency syndrome (AIDS) or AIDS related symptoms various immunological measurements were studied in a group of homosexual men attending screening clinics for AIDS in Copenhagen. Fifty seven men whose ratio of T helper lymphocytes to T suppressor lymphocytes (CD4:CD8 ratio) was less than 1.0 before the study began were included. Forty two were positive for antibody to the human immunodeficiency virus (HIV), of whom 38 were reinvestigated after a median observation period of 10 months. Among the seropositive men the transformation responses to pokeweed mitogen and cytomegalovirus and the absolute count of CD4 positive lymphocytes were the most common abnormal values. In particular, a low relative response to pokeweed mitogen on initial investigation correlated with a worsened clinical condition on reinvestigation. The risk of a worsened clinical condition was 55 times higher in seropositive men whose responses to pokeweed mitogen were low than in other seropositive men. The corresponding relative risks for low transformation responses to cytomegalovirus and for a decreased absolute count of CD4 positive lymphocytes were 18 and six. The relative response to pokeweed mitogen is therefore a very sensitive short term predictive marker of the clinical condition of seropositive patients who have a CD4:CD8 ratio of less than 1.0.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820544      PMCID: PMC1247139          DOI: 10.1136/bmj.295.6593.293

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  11 in total

1.  Human immunodeficiency viruses.

Authors:  J Coffin; A Haase; J A Levy; L Montagnier; S Oroszlan; N Teich; H Temin; K Toyoshima; H Varmus; P Vogt
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

2.  HTLV-III antibody testing in three Danish blood banks.

Authors:  B Orskov Lindhardt; K Ulrich; L Ryder; E Dickmeiss; H Sørensen; J Jørgensen; C Jersild; N Grunnet
Journal:  Vox Sang       Date:  1986       Impact factor: 2.144

3.  Occurrence of anti-HTLV-III antibodies in Danish high-risk homosexuals in 1982-83--seroconversion rate and risk of AIDS.

Authors:  B Hofmann; P Platz; N Odum; L P Ryder; A Svejgaard; N S Pedersen; J O Nielsen; V Faber; H H Sprechler; J Oehlenschlager
Journal:  AIDS Res       Date:  1986-02

4.  The isolation and characterization of the human helper inducer T cell subset.

Authors:  C Morimoto; N L Letvin; A W Boyd; M Hagan; H M Brown; M M Kornacki; S F Schlossman
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

5.  Three-year prospective study of HTLV-III/LAV infection in homosexual men.

Authors:  J N Weber; J Wadsworth; L A Rogers; O Moshtael; K Scott; T McManus; E Berrie; D J Jeffries; J R Harris; A J Pinching
Journal:  Lancet       Date:  1986-05-24       Impact factor: 79.321

6.  Immunological changes in lymphadenopathy virus positive and negative symptomless male homosexuals: two years of observation.

Authors:  K Schwartz; B R Visscher; R Detels; J Taylor; P Nishanian; J L Fahey
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

7.  Humoral responses to Pneumocystis carinii in patients with acquired immunodeficiency syndrome and in immunocompromised homosexual men.

Authors:  B Hofmann; N Odum; P Platz; L P Ryder; A Svejgaard; P B Nielsen; W Holten-Andersen; J Gerstoft; J O Nielsen; M Mojon
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

8.  Unexplained lymphadenopathy in homosexual men. A longitudinal study.

Authors:  D B Fishbein; J E Kaplan; T J Spira; B Miller; L B Schonberger; P F Pinsky; J P Getchell; V S Kalyanaraman; J S Braude
Journal:  JAMA       Date:  1985-08-16       Impact factor: 56.272

Review 9.  Unexplained persistent lymphadenopathy in homosexual men and the acquired immune deficiency syndrome.

Authors:  J W Gold; C S Weikel; J Godbold; C Garcia; C Urmacher; S Cunningham-Rundles; B Koziner; M Pollack; R C Gallo; M G Sarngadharan
Journal:  Medicine (Baltimore)       Date:  1985-05       Impact factor: 1.889

10.  Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells.

Authors:  B Hofmann; N Odum; B K Jakobsen; P Platz; L P Ryder; J O Nielsen; J Gerstoft; A Svejgaard
Journal:  Scand J Immunol       Date:  1986-06       Impact factor: 3.487

View more
  24 in total

1.  Proliferative responses of blood mononuclear cells (BMNC) in a cohort of elderly humans: role of lymphocyte phenotype and cytokine production.

Authors:  H Bruunsgaard; A N Pedersen; M Schroll; P Skinhøj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  CD28 costimulation and CD28 expression in T lymphocyte subsets in HIV-1 infection with and without progression to AIDS.

Authors:  H Choremi-Papadopoulou; N Panagiotou; E Samouilidou; F Kontopidou; V Viglis; A Antoniadou; J Kosmidis; T Kordossis
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

3.  Spontaneous release of interferon as a predictor of clinical evolution in HIV-positive subjects.

Authors:  A Biglino; A Surbone; F Lipani; N Cappello; B Forno; A M Pollono; M Busso; A Pugliese
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

Review 4.  Antibody responses in HIV infection.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 5.  B cell responses to HIV and the development of human monoclonal antibodies.

Authors:  J E Boyd; K James
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 6.  Immune dysregulation and CD4+ T cell loss in HIV-1 infection.

Authors:  L Meyaard; F Miedema
Journal:  Springer Semin Immunopathol       Date:  1997

7.  IgD production and other lymphocyte functions in HIV infection: immaturity and activation of B cells at different clinical stages.

Authors:  L A Rogers; S M Forster; A J Pinching
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

8.  Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals.

Authors:  T Jehuda-Cohen; B A Slade; J D Powell; F Villinger; B De; T M Folks; H M McClure; K W Sell; A Ahmed-Ansari
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes.

Authors:  B Hofmann; P Nishanian; T Nguyen; P Insixiengmay; J L Fahey
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

10.  In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection.

Authors:  S Rusconi; A Riva; L Meroni; G Zehender; F Cocchi; L Scapellato; M Galli
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.